The Tax protein encoded by human T-cell leukaemia virus type 1 (HTLV-1) has a pivotal role in T-cell transformation by deregulating cellular signalling pathways. Using the yeast two-hybrid system to screen a human leukocyte cDNA library, we identified BCL6 (B-cell lymphoma 6) as a cellular protein, which interacts with Tax 1. The BCL6 gene encodes a sequence-specific transcriptional repressor that contains a conserved N-terminal poxvirus and zinc finger (POZ) repressor domain and a C-terminal Kruppel-like zinc finger DNA binding domain. Using both in vivo and in vitro methods, we demonstrate that the POZ domain of BCL6 is sufficient for its interaction with Tax 1. Using functional assays, we demonstrate that Tax 1 enhanced the repressive activity of BCL6 and increased the levels of apoptosis induced by BCL6 in osteosarcoma cells indicating that both proteins cooperate in vivo to cause a physiological affect. Furthermore, BCL6 recruited Tax 1 into punctate nuclear structures, which suggests that Tax 1 colocalizes with BCL6 in repressor complexes in vivo. BCL6 expression significantly downregulated both basal and Tax-induced nuclear factor-jB and long terminal repeat activation. This suggests that the expression of BCL6 in HTLV infected cells may contribute to the silencing of viral gene expression and to the long clinical latency associated with HTLV infection.
Introduction
Human T-cell leukaemia virus type 1 (HTLV-1) is an oncogenic retrovirus that causes adult T-cell leukaemia (ATL) and a neurodegenerative disease termed tropical spastic paraparesis or HTLV-1-associated myelopathy (TSP/HAM; Poiesz et al., 1980; Yoshida et al., 1982; Gessain et al., 1985; Osame et al., 1986) . HTLV-1 infects 10-20 million people worldwide with 1-2% developing TSP/HAM and a further 2-3% developing ATL. The oncogenic potential of HTLV-1 is strongly associated with the viral Tax 1 protein. Tax 1 induces immortalization and transformation of primary rodent fibroblasts (Pozzatti et al., 1990; Tanaka et al., 1990) and primary human T cells (Grassmann et al., 1989 (Grassmann et al., , 1992 in vitro, and expression in vivo leads to the development of leukaemia and lymphoma in transgenic animals (Hasegawa et al., 2006) . Tax 1 is not a direct DNAbinding protein but modulates the expression of cellular and viral genes by interacting with transcription factors involved in several signalling pathways. Specifically, Tax enhances transcription of the viral genome from the long terminal repeat (LTR) by interacting with cyclic AMP response element-binding protein/activating transcription factor (CREB/ATF) and p300/CBP-associated factor (PCAF), which increases their affinity for cAMP responsive elements (CRE) within the LTR (Zhao and Giam, 1991; Suzuki et al., 1993; Jiang et al., 2000) . Activation of the nuclear factor (NF)-kB pathway by Tax 1 has a critical role in events leading to ATL development (Sun and Yamaoka, 2005; Matsuoka and Jeang, 2007) . However, persistent NF-kB activation occurs in freshly isolated ATL cells despite an inability to detect Tax 1 or other viral gene products, indicating that Tax-independent mechanisms are involved in maintaining ATL cells at the later stages of the disease , Hironaka et al., 2004 .
The B-cell lymphoma 6 (BCL6) gene is located on chromosome 3q27 and is frequently translocated or mutated in diffuse large B-cell lymphomas (DLBCL) and follicular lymphomas (Baron et al., 1993; Kerckaert et al., 1993; Ye et al., 1993; Chen et al., 1998) and in approximately 20% of acquired immunodeficiency syndrome (AIDS)-related non-Hodgkin's lymphomas (NHLs) (Gaidano et al., 1994) . These findings suggest that the over expression of BCL6 contributes to the pathogenesis of these disorders.
In normal lymphocytes, BCL6 is preferentially expressed in germinal centre (GC) B cells but not in immature or differentiated B cells (Cattoretti et al., 1995; Onizuka et al., 1995) . In T cells, BCL6 has an important role in the generation and maintenance of memory CD4 þ and CD8 þ T cells (Ichii et al., 2002 (Ichii et al., , 2007 . It is selectively expressed in most double-positive and double-negative thymocytes and its expression is linked to the pathogenesis of precursor T-cell lymphoblastic lymphoma (Hyjek et al., 2001) .
BCL6 belongs to the POK (poxvirus and zinc finger (POZ)/Kruppel) family of proteins and functions as a potent sequence-specific transcriptional repressor (Albagli et al., 1996; Chang et al., 1996; Seyfert et al., 1996) . The N-terminal POZ domain is required for the repressive function of BCL6, although the central region between the POZ and the C-terminal zinc finger domains can also mediate repression to a lesser extent. The BCL6 POZ domain mediates transcriptional repression by interacting with several corepressors including silencing mediator for retinoid and thyroid receptor (SMRT) and nuclear hormone receptor corepressor (NCoR; Huynh and Bardwell, 1998) , BCL6 corepressor (BCoR; Huynh et al., 2000) together with many histone deacetylases (HDACs; Lemercier et al., 2002) . In vivo, BCL6 colocalizes with these corepressors in punctate nuclear structures that have been identified as sites of ongoing DNA replication .
In this study, we demonstrate that Tax 1 interacts with the POZ domain of BCL6 and another closely related POZ-ZF protein, promyelocytic leukaemia zinc finger (PLZF). We demonstrate that this interaction enhances the repressive activity of BCL6 and increased the levels of apoptosis induced by BCL6 in osteosarcoma cells. We show that BCL6 recruits Tax 1 into punctate nuclear structures. BCL6, on the other hand, strongly repressed both basal and Tax-induced NF-kB and LTR activation. This suggests that BCL6 may contribute to the silencing of viral gene expression and to the long clinical latency associated with HTLV infection.
Results
Identification of BCL6 as a cellular protein that interacts with Tax 1 in a yeast two-hybrid screen The yeast two-hybrid approach was used to screen a human leukocyte cDNA library for proteins capable of interacting with Tax 1. From the positive clones resulting from nutritional and colorimetric selection, one clone was found to contain a cDNA of 3536 nucleotides encompassing the full-length open reading frame of the BCL6 protein (GenBank accession no. NM 001706).
Tax 1 interacts directly with the POZ domains of BCL6 and PLZF in vitro The initial observations of an interaction between BCL6 and Tax 1 using the yeast two-hybrid screen were confirmed in vitro by glutathione S-transferase (GST) pull-down assays (Figure 1 ). BCL6 deletion mutants were generated to determine the region of the protein involved in the interaction (Figure 1a) . Tax 1 was found to interact with a mutant protein comprising the N-terminal 519aa of BCL6 (BCL6 1À519 ), but not with the C-terminal 206aa (BCL6 500À706 ), which incorporates the six DNA binding Kruppel-like zinc fingers (Figure 1b ). Further pull downs showed an interaction between Tax 1 and BCL6 residues 1-174 (BCL6 1À174 ), and 130-706 (BCL6 130À706 ) but not with a protein comprising amino acids 164-706 (BCL6 164À706 ). Tax 1 was also found to interact with BCL6 1À130 , which comprises the POZ domain alone. These results show that Tax 1 interacts with a region of BCL6 that is overlapping the POZ domain and amino-acid residues 130-164.
Having confirmed that BCL6 and Tax 1 interact in vitro and because of the highly conserved nature of the POZ domains of POZ-ZF proteins (Stogios et al., 2005) , we examined the possibility that Tax 1 may also (b) Glutathione S-transferase (GST) pull-down assays were performed using purified GST or GST BCL6 wild-type and deletion proteins and purified Tax 1-HIS. The presence of Tax 1 in eluates from rebound GST-tagged proteins was detected by western blot analysis using an anti-HIS antibody. The relative amounts of GST-tagged proteins in the eluates were detected by comassie blue (CB) staining. (c) GST pull-down of GST, GST PLZF WT or GST PLZF POZ incubated with Tax 1. Tax 1 and the relative amounts of GST fusion proteins were detected in eluates as described in (b).
interact with another POZ-ZF protein, PLZF. The POZ domains, as well as the central domains of both BCL6 and PLZF, interact with similar corepressor complexes and both proteins function as sequence-specific transcriptional repressors (Dhordain et al., 2000; Melnick et al., 2002) . Using the GST pull-down assay, bacterially expressed GST-PLZF and Tax 1 proteins were found to interact and the interaction involved the POZ domain of PLZF (Figure 1c ). This suggests that cellular proteins containing POZ motifs may represent a previously unidentified family of proteins that interact with Tax 1.
In vivo Interaction of Tax 1 and BCL6 To determine whether the interaction between Tax 1 and BCL6 takes place in mammalian cells, 293T cells were cotransfected with Tax 1-HIS and FLAG-BCL6 fulllength, deletion mutants or the epitope alone expression plasmids. Lysates were precipitated with nickel resin and probed for BCL6 by western blot using anti-FLAG antibody. Figure 2 shows that Tax 1 and full-length BCL6 interact in vivo (first panel) and that this interaction involves the 130aa POZ region (third panel). However, as in the in vitro study, the BCL-6 interaction domain is not limited to the POZ region alone, as a weak interaction was observed for the BCL6 130À706 deletion mutant. Together, the in vivo and in vitro studies confirm that BCL6 and Tax 1 interact and that this interaction involves the POZ domain and possibly an additional POZ carboxy-flanking region.
Subcellular localization of BCL6 and Tax 1
Previous studies have shown that BCL6 localizes in punctate nuclear bodies in vivo (Dhordain et al., 1995) where it associates with corepressors such as SMRT and NCoR (Huynh and Bardwell, 1998) and BCoR (Huynh et al., 2000) . Furthermore, these structures were identified as sites of on going DNA synthesis , which suggests that these structures are strongly linked to the ability of BCL6 to repress transcription. In an effort to further substantiate the interaction between Tax 1 and BCL6 in mammalian cells, Cos7 cells were transfected with FLAG-tagged BCL6 and green fluorescent protein (GFP)-Tax 1 expression plasmids. Immunofluorescence staining showed that BCL6 recruits Tax 1 into small and large puncate nuclear structures (Figure 3c ; left panel) where both proteins appear to colocalize (Figure 3c ; right panel). The redistribution of Tax to these distinctive nuclear structures is in sharp contrast to the nuclear/ cytoplasmic staining pattern obtained with Tax 1 alone ( Figure 3a ; left panel).
Tax 1 increases the repressive activity of BCL6 in a POZ-dependent manner We next examined the consequences of the interaction between BCL6 and Tax 1 on the repressive activity of BCL6 using a luciferase reporter construct comprising five copies of the BCL6 recognition sequence upstream of the SV40 promoter. Transient transfection reporter assays showed that, although the addition of exogenous BCL6 alone repressed luciferase activity by over 3-fold compared to basal levels, the inclusion of Tax 1 enhanced this repression to more than 9-fold ( Figure 4 ). The repressive activities of BCL6 mutants lacking the POZ domain (BCL6 130À706 , BCL6 164À706 ) were lower than the wild-type (BCL6 WT ) levels and were not substantially increased by the addition of Tax 1. These results indicate that Tax 1 enhances the repressive activity of BCL6 via interaction with the BCL6 POZ domain.
Tax 1 enhances BCL6-induced apoptosis
Several studies have shown that the enforced expression of BCL6 can trigger apoptosis in some non-B cell lines (Albagli et al., 1999; Yamochi et al., 1999; Zhang et al., 2001) . Using a tetracycline-regulated expression system in osteosarcoma cells (UTA-L1), induction of BCL6 expression by the removal of tetracycline was reported to suppress cell-cycle progression and trigger apoptosis after several days of culture (Albagli et al., 1999) . These effects appeared to depend on the N-terminal domain of BCL6 as cells expressing only the zinc finger domain did not display the same phenotype. To determine if, through its interaction with POZ domain of BCL6, Tax 1 could alter the ability of BCL6 to induce apoptosis in these cells, UTA-L1 cells were transfected with either GFP-Tax 1 or GFP-GST expression plasmids in the presence (Tet þ ) and absence (TetÀ) of tetracycline. The level of apoptosis and necrosis was measured in GFP-positive cells using flow cytometry 96 h posttransfection ( Figure 5 ). In the absence of BCL6 expression (Tet þ ) similar levels of necrosis or apoptosis were observed in GFP-Tax 1 and GFP-GST cells (Figures 5a and b) . However in the presence of BCL6 (TetÀ) a higher proportion of apoptotic and necrotic cells was detected in GFP-Tax 1 expressing cells compared to those expressing GFP-GST. These results Figure 2 In vivo interaction of Tax 1 and B-cell lymphoma 6 (BCL6). 293T cells were cotransfected with the indicated combinations of the mammalian expression plasmids pCAGGS Tax 1-HIS and pFLAG BCL6 WT , BCL6 130À706 or BCL6 1À130 . Transfected cells were lysed after 24 h and coimmunoprecipitations were performed using nickel resin. The top panel shows an immunoblot of precipitates using an anti FLAG antibody to detect bound BCL6 proteins. Expression levels of both proteins was confirmed by direct western blotting of the lysates as shown in the two lower panels using anti-FLAG to detect BCL6 and anti-HIS to detect Tax 1.
indicate that Tax enhances the ability of BCL6 to induce apoptosis and necrosis in these cells. To establish the localization of Tax 1 in these cells, UTA-L1 cells were transfected with GFP-Tax 1 and cultured in the absence of tetracycline to induce BCL6 expression. Immunofluorescence clearly showed that GFP-Tax 1 alone displayed a diffuse nuclear/cytoplasmic localization in these cells (indicated by an open arrow in Figure 5d ) and was redistributed to nuclear bodies in the presence of BCL6 (indicated by a solid arrow in Figure 5d ). This suggests that the colocalization of Tax 1 and BCL6 in nuclear structures may be involved in the elevated levels of apoptosis observed in these cells. It is also consistent with the localization of BCL6 and Tax 1 in Cos 7 cells (Figure 3 ).
BCL6 downregulates Tax 1 activation of the NF-kB pathway
Having established the effect of Tax 1 on BCL6 activity, we next examined the influence of BCL6 on the function of Tax 1. BCL6 inhibited Tax 1-induced and basal levels of NF-kB activity in 293T cells in a dose-dependent manner (Figure 6a ). The level of repression was significantly higher in experimental systems containing Tax 1 (Figure 6c ) compared to the effect of BCL6 on basal activity (Figure 6d) . Furthermore, strong repressive activity by the BCL6 130À706 and BCL6 1À519 deletion mutants suggests that the central repressive domain of BCL-6 has a role in inhibiting NF-kB activity in both cases. Analysis of the subcellular localization of these BCL6 mutants showed that in contrast to the nuclear distribution of BCL6 WT and BCL6 130À706 , BCL6 1À519 and BCL6 1À130 mutants displayed predominantly cytoplasmic distributions (Figure 7 ). This suggests that BCL6 might inhibit NF-kB activity by mechanisms that are independent of DNA binding.
BCL6 represses basal and Tax 1-induced activation of the viral LTR
In addition to activating the NF-kB pathway, Tax 1 is also a potent activator of the HTLV-1 viral LTR. Functional assays demonstrated that BCL6 repressed both basal and Tax-induced LTR activities (Figure 8) . Repression of basal LTR activity by BCL6 appeared to involve only the POZ domain, as a mutant lacking the POZ domain BCL6 130À706 had no effect on basal activity (Figure 8a ). On the other hand repression of Tax 1-induced LTR activation appeared to involve the central repressive domains of BCL6 as demonstrated by the ability of BCL6 130À706 to repress activity in a manner similar to the wild-type protein (Figure 8b ). However, the repressive effect of BCL6 in the presence of Tax 1 was substantially diminished by increasing the amount of exogenous Tax added to the assays indicating that Figure 3 Colocalization of B-cell lymphoma 6 (BCL6) and Tax 1 in nuclear structures. Immunofluorescence was performed on Cos7 cells transfected with expression plasmids that code for green fluorescent protein (GFP)-Tax 1 (green) and FLAG-BCL6 (red). BCL6 was detected using anti-FLAG M2 followed by anti-mouse IgG 1 Texas Red (TXRD). Panel (a) shows GFP-Tax 1 alone, panel (b) shows FLAG-BCL6 alone and panel (c) shows GFP-Tax 1 and FLAG-BCL6. Nuclei were stained using DAPI (blue). Immunofluorescence images were obtained using an Olympus BX50 microscope and DP70 camera.
Interaction of HTLV-1 Tax protein and BCL6
J Dean et al higher levels of Tax expression can overcome the repressive activity of BCL6 on the viral LTR (Figure 8c ). The ability of Tax to counteract the repression by BCL6 appeared to depend on the presence of the POZ domain as increasing the amount of Tax in the presence of BCL6 130À706 , only reduced, but did not reverse, its repressive effect on LTR activity. To further examine the effect of BCL6 on the ability of Tax 1 to activate the LTR, functional assays were carried out using a chromosomally integrated LTR linked to GFP (Delebecque et al., 2002) . FACS analysis showed that BCL6 repressed activation of this LTR, which appeared in this case to depend solely on the POZ domain ( Figure 8d ).
Discussion
BCL6 encodes a sequence-specific transcriptional repressor that belongs to the POK family of proteins. The POZ domain of BCL6 directly interacts with the corepressors SMRT and NCoR (Dhordain et al., 1997; Huynh and Bardwell, 1998) and BCoR (Huynh et al., 2000) in large complexes that contain mSIN3 (Dhordain et al., 1998) and several HDACs (Lemercier et al., 2002) .
The recruitment of such repressor complexes by the POZ domain of BCL6 is responsible for a large proportion of the repressive function of the protein.
In this study we identified BCL6 as a cellular protein that interacts with the HTLV-1 Tax protein and showed that this interaction involved the POZ domain of BCL6. We found that Tax 1 enhanced the repressive activity of BCL6 by as much as threefold, an effect that was dependent on the presence of the POZ domain. Even though Tax 1 is a powerful transactivator of transcription, it has also been shown to downregulate genes involved in cell-cycle progression (Kibler and Jeang, 2001) , genetic stability (Gabet et al., 2003) and host DNA repair (Jeang et al., 1990) . The recruitment of HDAC1 by Tax 1 was shown in a recent study to be involved in the repression of the tumour suppressor protein SH2-homology containing protein-tyrosine phosphatase-1 (Cheng et al., 2007) . Even though it is not clear how Tax 1 enhances the repressive activity of BCL6, it is possible that the physical interaction between the POZ domain of BCL6 and Tax 1 recruits Tax to BCL6 target genes where Tax 1 may recruit additional repressors.
The role of BCL6 in cell survival appears to be cell specific. On one hand BCL6 promotes the survival and proliferation of GC B cells in the presence of genome instability resulting from class-switch recombination and somatic hypermutation of immunoglobulin genes (Baron et al., 2002 (Baron et al., , 2007 Phan and Dalla-Favera, 2004; Phan et al., 2005) . Inhibition of apoptosis and cell-cycle arrest in such cells is related to the ability of BCL6 to repress the expression of DNA damage sensing proteins such as p53 (Phan and Dalla-Favera, 2004 ) and ATR (Ranuncolo et al., 2007) and the cyclin-dependent kinase inhibitor p21 (Phan et al., 2005) . Conversely, BCL6 induces apoptosis in CV-1 and HeLa cells (Yamochi et al., 1999) , osteosarcoma cells (Albagli et al., 1999) , NIH3T3 cells (Zhang et al., 2001 ) and normal fibroblasts (Ranuncolo et al., 2008) . We show that Tax 1 increased the level of apoptosis and necrosis in an osteosarcoma cell line that expresses BCL6 in a tetracycline-regulated system (Albagli et al., 1999) . The expression of Tax 1 and BCL6 in these cells resulted in the redistribution of GFP-Tax 1 to punctate nuclear bodies. These sites were previously described in colocalization studies involving BCL6 and the corepressors NCoR and SMRT (Dhordain et al., 1997; Huynh and Bardwell, 1998) and were identified as sites of on going DNA replication . Taken together these data suggest that BCL6 recruits Tax 1 together with various corepressors to nuclear sites of ongoing DNA replication where Tax 1 may enhance the repressive activity of BCL6 and increase the levels of apoptosis in these cells.
The HTLV-1 Tax protein is a powerful transactivator of both the viral LTR and the NF-kB pathway. BCL6 over expression in this study strongly repressed both Tax-induced and basal activation of the viral LTR. Repression of basal LTR activity by BCL6 appeared to exclusively involve the POZ domain. Examination of the LTR sequence identified several putative BCL6 binding sites, which raises the possibility that BCL6 represses basal LTR activation by binding the promoter and recruiting corepressors to that site via the POZ domain but this requires further investigation. BCL6 also strongly repressed Tax-induced activation of a chromosomally integrated LTR and a plasmid LTR. Repression of the plasmid LTR appeared to be dose dependent as the addition of higher concentrations of Tax 1 totally Interaction of HTLV-1 Tax protein and BCL6 J Dean et al abolished repression by BCL6 WT and reduced the ability of BCL 130À706 to repress transcription. The ability of Tax 1 to displace endogenous HDACs from the LTR and activate transcription has been previously reported (Lemasson et al., 2004; Lu et al., 2004) . These studies concluded that that activation or repression of the LTR depended on the local concentrations of Tax 1 and repressor complexes. A similar mechanism may be involved in the ability of excess Tax 1 to reverse the repressive effects of BCL6 on the LTR. Repression of the integrated LTR by BCL6 appeared to only involve the POZ domain, which is in contrast to the plasmid LTR where repression seemed to involve a central domain of BCL6. This may be related to the ability of the POZ domain of BCL6 to recruit the corepressor complexes necessary to induce a repressive state in the context of chromatin.
Our finding that BCL6 inhibits both basal and Taxinduced NF-kB activation in 293T cells is consistent with previous studies, which showed that NF-kB activity was inversely correlated with BCL6 expression in normal GC B cells and in DLBCL (Alizadeh et al., 2000; Shaffer et al., 2001) . Furthermore, BCL6 was reported to bind the promoter of the NF-kB1 (p50/ p105) gene and repress transcription (Li et al., 2005) . However, in our study a BCL6 mutant (B6 1À519 ) that lacks the DNA binding zinc finger domain of BCL6 and displays an exclusively cytoplasmic intracellular localization strongly repressed NF-kB activity. This suggests that BCL6 might interact with NF-kB members that are transported from the cytoplasm to the nucleus after activation of the pathway. This is supported by the findings in a recent study, which showed that BCL6 inhibits NF-kB activity in B cells by physically interacting with the Rel-homology domains of RelA/p65, RelB, p50 and p52 NF-kB subunits via the zinc finger domain (Perez-Rosado et al., 2008) . However in contrast to that study, our data show that the central domain spanning amino acids 130 to 519 and not the zinc finger domain is involved in downregulating both basal and Tax-induced NF-kB activations. Further investigation will be required to examine the mechanisms involved in the inhibition of Tax 1-induced NF-kB activation by BCL6.
Our study is the first to demonstrate the interaction of HTLV-1 Tax with the POZ/BTB protein-protein interaction domain. This domain is present in more than 200 human proteins, 25% of which also contain a C-terminal zinc finger domain, which defines the POK family (Stogios et al., 2005; Kelly and Daniel, 2006) . The conserved nature of the POZ domain would suggest that POZ containing proteins represent a new family of potential Tax interactors, a hypothesis supported by our own data showing the interaction of Tax 1 with the POZ domain of PLZF.
In conclusion, we show that the interaction between Tax 1 and BCL6 enhances transcriptional repression by BCL6. As BCL6 can either promote cell survival or induce apoptosis in a cell-specific manner, our data suggest Tax 1 expression may enhance those effects as shown by the increased levels of apoptosis induced by BCL6 in the presence of Tax 1 in this study. The role of BCL6 in ATL is not clear even though it is expressed at high levels in primary ATL cells compared to normal CD4 þ T cells (Nakayama et al., 2008) . Our finding that BCL6 downregulates NF-kB activity argues against a functional role for BCL6 after the development of ATL. However the ability of BCL6 to repress viral gene expression by downregulating the viral LTR suggests that BCL6 may silence viral gene expression and promote the survival of infected cells due to immune evasion. Consequently BCL6 may have a significant role in the establishment of clinical latency frequently associated with HTLV infection.
Materials and methods

Plasmid constructs
The expression plasmids, pCAGGS Tax 1, pEGFP-C1 Tax 1 and pEGFP-C1 GST, have been previously described Tsuji et al., 2007) . A PCR product encoding the Figure 7 Subcellular localization of BCL6 WT and B-cell lymphoma 6 (BCL6) mutants. Immunofluorescence was performed on Cos7 cells transfected with expression plasmids that code for FLAG-BCL6 WT or the indicated FLAG-BCL6 mutants. Expression of BCL6 proteins was detected using anti-FLAG M2 followed by anti-mouse IgG 1 fluorescein isothiocyanate (FITC; Green). Nuclei were stained using DAPI (Blue). Immunofluorescence images were obtained using an Olympus BX50 microscope and DP70 camera.
Interaction of HTLV-1 Tax protein and BCL6
J Dean et al full length of Tax 1 (amino acids 1-350) was generated using pCAGGS Tax 1 as template and was cloned into pAST2-1 (Clontech, Saint-Germain-en-Laye, France) to construct the bait plasmid for the yeast screening. The expression plasmid pTaxH 6 , kindly provided by JK Nyborg, was used to express Tax 1 in Escherichia coli (Zhao and Giam, 1991) . Wild-type BCL6 was PCR amplified from the yeast two-hybrid system prey vector pACTII (Clontech) and cloned into the bacterial expression plasmid pGEX-2T. The BCL6 deletion mutants (see Figure 1a) were cloned into pGEX-2T using PCR fragments amplified from the full-length BCL6 construct. Full-length PLZF was amplified using PCR from a human leukocyte cDNA library (Clontech) and cloned into pGEX-2T. The PLZF POZ domain was amplified from the full-length construct and subsequently cloned into pGEX-2T. For mammalian expression, the full-length and mutant BCL6 DNA fragments were subcloned from the pGEX constructs into pFLAG (Sigma Aldrich, Arklow, Ireland). The pGL3 LTR and NF-kB luciferase reporter constructs were previously described . To construct the BCL6 reporter construct, five copies of the BCL6 consensus binding sequence ('CTCTTTCCTAGAAATG') were cloned into the pGL3-promoter vector (Promega, Southampton, UK) using the Nhe1 and BglII restriction enzyme sites upstream of the SV40 promoter.
Yeast two-hybrid screening To conduct the screens, Saccharomyces cerevisiae Y190 reporter strain (Trp
) was sequentially transformed with the bait construct and the Human Leukocyte MATCHMAKER cDNA library (Clontech) and plated on minimal media lacking tryptophan, leucine and histidine, and containing 3-aminotriazole. All manipulations were carried out as described by Clontech (MATCHMAKER GAL4 twohybrid system 2).
Glutathione S-transferase pull-down assays GST and GST fusion proteins were expressed and purified as previously described (Tsuji et al., 2007) . Briefly, transformed E. coli BL21 cells were grown to an OD 600 of 1.2 at 37 1C and induced with 0.3 mM IPTG (isopropyl-1-thio-b-d-galactopyranoside) for 12 h at 18 1C. Cells were lysed by several rounds of freezing and thawing followed by sonication. Fusion proteins were purified by affinity chromatography using glutathione-sepharose-4B beads (GE Healthcare, Dublin, Ireland). The Tax 1 protein was expressed in E. coli BL21DE3 pLysS cells transformed with the pTaxH 6 vector and purified using Ni resin as previously described (Zhao and Giam, 1991; Giebler et al., 1997) . Rebound GST and GST fusion proteins were incubated with purified Tax 1 protein for 2 h at 4 1C. Bound proteins were eluted from the beads by incubation with a buffer containing 10 mM reduced glutathione, 50 mM Tris-HCL (pH8). The interaction of Tax 1 and GST fusion proteins was assessed by western blot using an antibody directed against the His tag.
Cell culture, transfections and coimmunoprecipitation 293T and Cos7 were grown in Dulbecco's modified Eagles medium supplemented with 10% fetal calf serum (FCS), 100 U/ml penicillin/streptomycin and 10 mg/ml kanamycin. The osteosarcoma cell line UTA-L1 was maintained in Gibco-F12 Glutamax-1 nutrient medium supplemented with 10% FCS, 1 mg/ml puramycin, 500 mg/ml geneticin G418 and 2 mg/ml tetracycline as previously described (Albagli et al., 1999) . BCL6 expression was induced by culturing the cells in tetracycline-free medium. All transfections were carried out using Fugene 6 (Roche Applied Sciences, Burgess Hill, UK) according to the manufacturers instructions. Transfected cells were lysed using a buffer containing 20 mM Tris pH 8, 150 mM NaCl, 1% Triton X and protease inhibitors (Complete Protease Inhibitor cocktail; Roche). In vivo interactions were detected by coprecipitations using nickel resin and western blot analysis using anti-Flag M2 antibody (Sigma Aldrich).
Immunofluorescence FLAG-BCL6 WT and GFP-Tax 1 expression plasmids were cotransfected into Cos7 cells using Fugene 6. Twenty-four hours later, the cells were fixed in 4% paraformaldehyde, permeabilized using 0.2% Tween 20 and stained using antiFlag M2 followed by anti-mouse IgG 1 Texas Red or antimouse IgG 1 fluorescein isothiocyanate (FITC; Southern Biotechnology, Cambridge, UK) as indicated. UTA-L1 cells cultured in the presence and absence of tetracycline were transfected with GFP-Tax 1 expression plasmid. After 48 h, the cells were fixed and permeabilized and BCL6 expression was detected using anti-FLAG antibody followed by antimouse IgG 1 -biotin. Positive cells were detected using Streptavidin Alexa 350 (Molecular Probes, Paisley, UK). Subcellular localization was determined using an Olympus fluorescence microscope (Olympus, Southend-on-Sea, UK).
Functional assays 293T cells were transfected with the indicated plasmids using Fugene 6 and luciferase reporter assays were performed as previously described . Each transfection was done in duplicate and luciferase activity was measured after 24 h using the Dual Luciferase Reporter Assay kit (Promega) according to the manufacturers instructions. 293T cells that contain a chromosomally integrated HTLV-1 LTR linked to GFP (Delebecque et al., 2002) were transfected with Tax and BCL-6 plasmids in a similar manner. GFP expression, indicative of LTR activation, was determined by FACS, using a FACSCalibur flow cytometer (Becton Dickinson, Oxford, UK). For both luciferase assays and FACS analysis, normalized values are reported as the mean fold repression of LTR activity ± s.d from three independent experiments.
Dead cell and apoptosis assays UTA-L1 cells, cultured in the presence and absence of tetracycline, were transfected with 150 ng of GFP-Tax 1 or GFP-GST expression plasmids. Ninety-six hours posttransfection, the cells were trypsinized, washed and initially stained for viability using the Live/Dead Fixable Red Dead stain kit according to the manufacturers instructions (Invitrogen, Paisley, UK). Apoptosis detection was carried out using Annexin V-biotin (Calbiochem) followed by detection with Streptavidin Alexa 647 (Molecular Probes, Nottingham, UK). Flow cytometry was carried out on a FACSCalibur (Becton Dickonson) electronically gating on transfected cells (GFPpositive).
